AXGN · Axogen, Inc. · Executive Compensation
Market Cap
$2.28B
Shares
53.76M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Michael Dale | CEO and President | $9,047,454 |
| Marc Began | Executive Vice President and GC | $3,063,430 |
| Jens Kemp | Chief Marketing Officer | $2,279,206 |
| Erick DeVinney | Chief Innovation Officer | $2,261,741 |
| Lindsey Hartley | CFO | $1,935,226 |
| Nir Naor | — | $271,544 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Michael Dale | CEO and President | $8,847,922 |
| Nir Naor | CFO | $3,048,882 |
| Former CFO | — | $3,048,882 |
| Karen Zaderej | Former CEO and President | $2,475,627 |
| Erick DeVinney | — | $2,266,567 |
| Marc Began | EVP, GC | $1,847,574 |
| Jens Kemp | — | $1,745,971 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Karen Zaderej | Former CEO and President | $5,534,681 |
| Peter Mariani | Executive Vice President, CFO | $2,911,758 |
| Angelo Scopelianos | Chief Research and Development Officer | $1,819,479 |
| Michael Donovan | Vice President, Operations | $1,566,893 |
| Erick DeVinney | Vice President , Peripheral Nerve Science | $1,505,697 |
| Chief Innovation | Officer | $1,505,697 |
| Former CFO | — | $60,291 |
| Nir Naor | CFO | $60,291 |
| Michael Dale | CEO and President | — |
| Marc Began | EVP, GC | — |
| Chief Marketing | Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Karen Zaderej | Former CEO and President | $4,398,292 |
| Peter Mariani | Executive Vice President, CFO | $2,115,888 |
| Eric Sandberg | — | $1,912,071 |
| Angelo Scopelianos | Chief Research and Development Officer | $1,267,797 |
| Bradley Ottinger | General Counsel and Chief Compliance Officer | $1,215,819 |
| Michael Donovan | Vice President, Operations | $1,075,600 |
| Nir Naor | CFO | — |
| Michael Dale | CEO and President | — |
| Marc Began | EVP, GC | — |
| Chief Marketing | Officer | — |
| Chief Innovation | Officer | — |
| Erick DeVinney | Vice President , Peripheral Nerve Science | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Karen Zaderej | CEO and President | $5,360,575 |
| Peter Mariani | Executive Vice President, CFO | $2,647,183 |
| Angelo Scopelianos | Chief Research and Development Officer | $1,582,127 |
| Eric Sandberg | Chief Commercial Officer | $1,529,359 |
| Former Chief Commercial | Officer | $1,529,359 |
| Maria Martinez | — | $1,526,164 |
| Michael Donovan | Vice President, Operations | — |
| Erick DeVinney | Vice President , Peripheral Nerve Science | — |
| Nir Naor | CFO | — |
| Bradley Ottinger | General Counsel and Chief Compliance Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Karen Zaderej | President, CEO | $4,051,482 |
| Peter Mariani | Executive Vice President , CFO | $1,487,078 |
| Bradley Ottinger | General Counsel and Chief Compliance Officer | $1,304,826 |
| Eric Sandberg | Chief Commercial Officer | $1,294,018 |
| Former Chief Commercial | Officer | $1,293,357 |
| Angelo Scopelianos | Chief Research and Development Officer | $1,198,879 |
| Brad Ottinger | General Counsel and Chief Compliance Officer | $1,148,261 |
| Chief Human Resources | Officer | $1,038,974 |
| Michael Donovan | Vice President of Operations | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Eric Sandberg | Chief Commercial Officer | $1,113,442 |
| Karen Zaderej | President, CEO | $999,963 |
| Angelo Scopelianos | Chief Research and Development Officer | $554,136 |
| Peter Mariani | Executive Vice President , CFO | $548,032 |
| Chief Human Resources | Officer | $459,707 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Karen Zaderej | President, CEO | $3,665,188 |
| Angelo Scopelianos | Chief Research & Development Officer | $1,520,624 |
| Peter Mariani | CFO | $1,439,007 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lindsey Hartley | Chief Financial Officer (CFO) | Appointed | 2025-05-08 |
| Lindsey Hartley | Chief Financial Officer | Appointed | 2025-05-08 |
| Paul Thomas | Chairman of the Board of Directors | Appointed | 2024-08-09 |
| Paul G. Thomas | Chair of the Board | Appointed | 2024-08-09 |
| Michael Dale | member of the Board | Appointed | 2024-08-09 |
| Michael Dale | Chief Executive Officer | Appointed | 2024-08-09 |
Key facts
CIK
805928
CUSIP
05463X106
13F (30d)
124 filings
123 filers
Visit website
Investor relations